Interstitial myocardial fibrosis in a captive chimpanzee (Pan troglodytes) population

Comparative Medicine

Volumn 58, Issue 4, 2008, Pages 389-394

  Lammey, Michael L ^a   Baskin, Gary B ^b   Gigliotti, Andrew P ^c   Lee, D Rick ^a   Ely, John J ^a   Sleeper, Meg M ^d  

^a Alamogordo Primate Facility   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; BLOOD PRESSURE; CARDIOMYOPATHY; CHIMPANZEE; CONGESTIVE HEART FAILURE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HEPATOMEGALY; HISTOPATHOLOGY; HYPERTENSION; INTERSTITIAL MYOCARDIAL FIBROSIS; KIDNEY FAILURE; NONHUMAN; PHYSICAL EXAMINATION; SEPTICEMIA; SUDDEN DEATH;

ANIMALS; ANIMALS, LABORATORY; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; ENDOMYOCARDIAL FIBROSIS; FEMALE; FIBROSIS; HUMANS; MALE; MYOCARDIUM; PAN TROGLODYTES; RETROSPECTIVE STUDIES;

EID: 51549096913     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Agresti A. 2002. Categorical data analysis, 2nd ed. New York: Wiley.
2. Allessie M, U Schotten, S Verheule, E Harks. 2005. Gene therapy for repair of cardiac fibrosis: a long way to Tipperary. Circulation 111:391-393
3. Baskins G. 2006. Personal communication.
4. Barbara G. 2005. HIV-associated cardiomyopathy: etiopathegenesis and clinical aspects. Herz 30:486-492.
5. Borkowski R, Taylor TG, Rush J. 2000. Cerebral infarction and myocardial fibrosis in a white-handed gibbon (Hylobates lar). J Zoo Wildl Med 31:65-70.
6. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman J, Thillet J, Michel JB. 1995. The effects of salt intake on blood pressure of chimpanzees. Nat Med 1:1009-1016.
7. de Souza RR. 2002. Aging of myocardial collagen. Biogerontology 3:325-335.
8. Doane CJ, Lee DR, Sleeper MM. 2006. Electrocardiogram abnormalities in captive chimpanzees. Comp Med 56:512-518.
9. Eichberg JW, Shade RE. 1987. 'Normal' blood pressure in chimpanzees. J Med Primatol 16:317-321.
10. Fienberg SE. 1980. The analysis of cross-classified categorical data. Cambridge (MA): MIT Press
11. Fincham JE, Woodroof CW, van Wyk D, Capatos D, Weight MJ, Krichevsky D, Rossouw JE. 1987. Promotion and regression of atheroscerosis in vervet monkeys by diets realistic for westernized people. Atherosclerosis 66:205-213.
12. Frick H. 1973. Heart of the chimpanzee. In: Bourne GH, editor. The chimpanzee: immunology, infection, hormones, anatomy, and behavior, vol 3. Baltimore (MD): University Park Press. p 295-336.
13. Guntaka RV, Weber KT. 2005. Molecular strategies for the prevention of cardiac fibrosis. In: Villareal FJ, editor. Interstitial fibrosis in heart failure. New York: Springer Media. p 329-341.
14. Hansen JF, Alford PL, Keeling ME. 1984. Diffuse myocardial fibrosis and congestive heart failure in an adult male chimpanzee. Vet Pathol 21:529-531.
15. Hubbard GB, Lee DR, Eichberg JW. 1991. Diseases and pathology of chimpanzees at the Southwest Foundation for Biomedical Research. Am J Primatol 24:273-282.
16. Iskander SB, Loyd S, Downs CJ, Roy TM. 2004 Hepatitis C and dilated cardiomyopathy. TN Med 97: 31-33.
17. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T. 2004. Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43:739-745.
18. Lecomte D, Fornes P, Fouret P, Nicolas G. 1993. Isolated myocardial fibrosis as a cause of sudden cardiac death and its possible relation to myocarditis. J Forensic Sci 38:617-621.
19. Levick SP, Loch DC, Taylor SM, Janicki JS. 2007. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 178:641-646.
20. Li JK-J, Zhu Y, Noordegraaf A. 2006. A comparative approach to analysis and modeling of cardiovascular function. In: Bronzino JD, editor. Biomedical engineering fundamentals. Boca Raton (FL): CRC Press. p 17.1-17.12.
21. Masson S, Latini R, Salio M, Fiordalsio F. 2005. Cardiac fibrosis and aging. In: Razzaque M, editor. Fibrogenesis: cellular and molecular basis. Austin (TX): Landes Bioscience. p 97-103.
22. Munson L, Montali RJ. 1990. Pathology and disease of great apes at the National Zoological Park. Zoo Biol 9:99-105.
23. National Research Council. 1997. Chimpanzees in research: strategies for their ethical care, management, and use. Committee on Long-Term Care of Chimpanzees Institute for Laboratory Animal on Life Sciences. Commission on Life Sciences. Washington (DC): National Academy Press.
24. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academy Press.
25. Nicoletti A, Michel JB. 1999. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc Res 41:532-543.
26. Pick R, Janicki JS, Weber KT. 1989. Myocardial fibosis in nonhuman primate with pressure overload hypertrophy. Am J Pathol 135:771-781.
27. Roffe C. 1998. Ageing of the heart. Br J Biomed Sci 55:136-148.
28. Saeed A, Guron G, Oldfors A, Lindelow B, Herlitz H. 2006. Cardiac fibrosis triggered by the kidney: a case report. Nephrol Dial Transplant 21:1713-1715.
29. Schulman FY, Farb A, Virmani R, Montali RJ. 1995. Fibrosing cardiomyopathy in captive western lowland gorillas (Gorilla gorilla gorilla) in the United States: a retrospective study. J Zoo Wildl Med 26:43-51.
30. Shannon RP. 2001. SIV cardiomyopathy in nonhuman primates. Trends Cardiovasc Med 11:242-246.
31. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, Lacker AA. 2000. Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 101:185-193.
32. Shibasaki Y, Nishiue T, Masaki H, Yamura K, Matsumoto N, Mori Y, Nishikawa M, Matsubara H, Iwasaka T. 2005. Impact of angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal failure: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 28:787-795.
33. Silver MA, Rowley NE. 1988. The functional anatomy of the human coronary sinus. Am Heart J 115:1080-1084.
34. Sleeper MM, Doane CJ, Langner PH, Curtis SK, Avila K, Lee DR. 2005. Successful treatment of idiopathic dilated cardiomyopathy in an adult chimpanzee (Pan troglodytes). Comp Med 55:80-84.
35. Sun Y, Weber KT. 2005. Animal models of cardiac fibrosis. Methods Mol Med 117:273-290.
36. Szczech L, Chew D, Coladonato J, Reddan D. 2002. The heart and the renal system. In: Topol, editor. Textbook of cardiovascular disease, 2nd ed. Philadelphia: Lippencott, Williams, and Wilkins. p 799-814.
37. Tyralla K, Amann K. 2002. Cardiovascular changes in renal failure. Blood Purif 20:462-465.
38. Weber KT. 2004. Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts. J Hypertens 22:47-50.
39. Weber KT, Brilla CG. 1991. Pathological hypertrophy and cardiac interstitium. Fibrosis and the rennin-angiotensin-aldosterone system. Circulation 83:1849-1865.
40. Wigley FM. 2004. Scleroderma (systemc sclerosis). In: Goldman L, Ausiello D, editors. Cecil textbook of medicine. Philadelphia: Saunders. p 1674-1675.
41. Yu HC, Burrell LM, Black MJ, Dilley RJ, Cooper ME, Johnston CI. 1998. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621-2628.
42. Zipes DP, Rupart M. 2006. Neural modulation of cardiac arrhythmias and sudden death. Heart Rhythm 3:108-113.